VitaNova Life Sciences (VNOV) Other financing activities (2017 - 2025)

VitaNova Life Sciences has reported Other financing activities for 6 years, with the latest figure at $500.0 in Q1 2025.

• For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $500.0; the trailing twelve-month figure through Apr 2025 stood at $2000.0 (changed N/A YoY), and the FY2025 full-year result was $2000.0, up 100.0% from the prior year.
• Other financing activities for Q1 2025 stood at $500.0, down from $750.0 in the prior quarter.
• The five-year high for Other financing activities was $17282.0 in Q3 2023, with the low at -$17282.0 in Q4 2023.
• Historically, Other financing activities has averaged $400.0 across 3 years, with a median of $750.0 in 2024.
• The largest YoY upside for Other financing activities was 104.34% in 2024 against a maximum downside of 95.66% in 2024.
• VitaNova Life Sciences' Other financing activities stood at -$17282.0 in 2023, then surged by 104.34% to $750.0 in 2024, then plunged by 33.33% to $500.0 in 2025.
• The last three Other financing activities figures came in at $500.0 (Q1 2025), $750.0 (Q4 2024), and $750.0 (Q3 2024), per Business Quant data.